Tags: canada + drug company.with.MS

Sort by: Date / Title / URL

1. BioMS Medical Announces Lead Investigator In United States Phase III Multiple Sclerosis Trial
   BioMS Medical Corp (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), is pleased to announce Dr. Clyde E. Markowitz as the lead investigator in the United States for the Company’s pivotal phase III clinical trial of its lead dru
   28-04-2007 to canada, drug company, drugs, mbp8298, multiple sclerosis, spms by admin
2. BioMS Medical Cleared by FDA to Initiate Pivotal Phase III Multiple Sclerosis Trial
   "The clearance to proceed with a phase III trial in the US is asignificant step towards bringing MBP8298 to the worldwide market," saidKevin Giese, President and CEO of BioMS Medical.
   20-01-2007 to canada, clinical trial, drug company, drugs, mbp8298, multiple sclerosis, secondary progressive by admin
3. Stem Cell Therapeutics Options Schizophrenia and Multiple Sclerosis Clinical Programs
   The multiple sclerosis program captured in the agreement has already completed a 24 week open label Phase IIa clinical study seeking improvement in walking distance and Kurtzke Expanded Disability Status Scale (EDSS) efficacy endpoints in chronic progress
   13-09-2006 to canada, clinical trial, drug company, multiple sclerosis, ppms, primary progressive, stemcell, treatment by admin
4. Chromos announces independent Multiple Sclerosis Advisory Board: Financial News - Yahoo! Finance
   Chromos Molecular Systems Inc. (TSX: CHR - News) has formed a Multiple Sclerosis (MS) Advisory Board to guide the Company's development of a promising novel treatment for MS.
   06-09-2006 to canada, chr-1103, drug company by admin
5. Genentech, Biogen say cancer drug helps against MS | Health | Reuters.co.uk
   Biotechnology companies Genentech Inc. and Biogen Idec Inc. on Monday said their cancer drug Rituxan showed hints of effectiveness against multiple sclerosis in a small mid-stage trial
   28-08-2006 to canada, chemotherapy, clinical trial, drug company, drugs, multiple sclerosis, research, rituxan, study, treatment, us by admin
6. BioMS Medical Announces Second Quarter 2006 Results
   More than 300 patients enrolled in pivotal phase II/III multiple sclerosis trial
   14-08-2006 to canada, clinical trial, drug company, drugs, multiple sclerosis, spms by admin
7. GW Pharmaceutical: Sativex
   GW pharmaceuticals is developing a portfolio of cannabis medicines the first of which, Sativex, received an Approval with Conditions from Health Canada in April 2005 for use as an adjunctive treatment for the symptom relief of neuropathic pain in MS
   17-07-2006 to canada, drug company, drugs, marijuana, multiple sclerosis, pain, sativex, uk by admin
8. Bioms Medical - Multiple Sclerosis
   BioMS Medical is a biotechnology company engaged in the development and commercialization of novel therapeutic technologies with emphasis on the treatment of multiple sclerosis (MS).
   17-06-2006 to canada, drug company, drugs, multiple sclerosis by admin
9. Welcome to MSWatch
   17-06-2006 to canada, drug company, multiple sclerosis by admin

First / Previous / Next / Last / Page 1 of 1